IGC Pharma (IGC) Treasury Shares (2018 - 2026)

IGC Pharma (IGC) has 9 years of Treasury Shares data on file, last reported at $5.2 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $5.2 million, down 10.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (down 10.97% YoY), and the FY2026 annual result was $5.2 million, down 10.97% from the prior year.
• Treasury Shares fell to $5.2 million in Q1 2026 per IGC's latest filing, from $6.1 million in the prior quarter.
• Over five years, Treasury Shares peaked at $8.5 million in Q2 2023 and troughed at $4.4 million in Q1 2023.
• A 5-year average of $6.6 million and a median of $6.5 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 3322.54% in 2022, then dropped 22.22% in 2025.
• A 5-year view of Treasury Shares shows it stood at $5.8 million in 2022, then soared by 47.26% to $8.5 million in 2023, then dropped by 14.77% to $7.3 million in 2024, then decreased by 15.47% to $6.1 million in 2025, then slipped by 16.06% to $5.2 million in 2026.
• Business Quant data shows IGC's Treasury Shares at $5.2 million in Q1 2026, $6.1 million in Q4 2025, and $6.5 million in Q3 2025.